Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
Fig. 5 A
Sullivan CH et al. (2019) |
Xla Wt + irx1-VP16
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 5 B
Sullivan CH et al. (2019) |
Xla Wt + irx1-VP16
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 5 C
Sullivan CH et al. (2019) |
Xla Wt + irx1-VP16
NF 24- NF 28 (in situ hybridization) |
|
||||
Fig. 5 D
Sullivan CH et al. (2019) |
Xla Wt + irx1-VP16
NF 24- NF 28 (in situ hybridization) |
|